BDSI. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone NDA target remains on course for the second quarter of 2013 http://finance.yahoo.com/news/biodelivery-sciences-announces-positive-results-110000456.html stockcharts.com/c-sc/sc?s=BDSI&p=W&yr=1&mn=0&dy=0&i=t61652955662&r=1347536365586